今开:0.0 | 昨收:0.19 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:4.6340117E7 |
wfan20222015-07-06 00:08
抗癌新药PV-10花落勃林格殷格翰,将在中国上市-观察-生物探索:网页链接 $PROVECTUS BIOPHARMACEUTICALS(PVCT)$查看全文
$Provectus生物制药(PVCT)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-20-003433 Act: 34 Size: 4 MB 网页链接
$Provectus生物制药(PVCT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-20-000307 Act: 34 Size: 144 KB 网页链接
$Provectus生物制药(PVCT)$ 8-K Current report, item 8.01 Accession Number: 0001493152-19-019701 Act: 34 Size: 28 KB 网页链接
$Provectus生物制药(PVCT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-19-016870 Act: 34 Size: 2 MB 网页链接
$Provectus生物制药(PVCT)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-08 AccNo: 0001493152-19-011851 Size: 2 MB 网页链接
$Provectus生物制药(PVCT)$ 8-K - Current report Filed: 2019-06-27 AccNo: 0001493152-19-009792 Size: 38 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Provectus生物制药(PVCT)$ 8-K - Current report Filed: 2019-05-20 AccNo: 0001493152-19-007778 Size: 154 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fina...
$Provectus生物制药(PVCT)$ DEF 14A - Other definitive proxy statements Filed: 2019-05-14 AccNo: 0001493152-19-007050 Size: 1 MB 网页链接
$Provectus生物制药(PVCT)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-05-14 AccNo: 0001493152-19-007052 Size: 461 KB 网页链接
$Provectus生物制药(PVCT)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-13 AccNo: 0001493152-19-006871 Size: 1 MB 网页链接